期刊文献+

肾细胞癌中bcl-2、p53、增殖细胞核抗原表达与细胞增殖和凋亡 被引量:1

Relationship between cell proliferation and apoptosis with bcl-2,p53,proliferating cell nuclear antigen expression in renal cell carcinoma
原文传递
导出
摘要 目的 探讨肾细胞癌 (RCC)中bcl 2、p5 3、增殖细胞核抗原 (PCNA)表达与细胞增殖、凋亡及病理参数之间的关系。方法 应用链霉亲和素辣根过氧化物酶 (SABC)法分析 3 4例RCC标本中bcl 2、p5 3和PCNA蛋白的表达 ,应用末端脱氧核苷酸转移酶介导的脱氧三磷酸尿苷(dUTP)缺口末端标记 (TUNEL)法检测细胞凋亡。结果  3 4例RCC标本中 ,15 ( 4 4.1% )例bcl 2阳性表达 ,表达阳性率与增殖指数 (PI)、凋亡指数 (AI)及RCC病理学参数无关 ;仅有 3例p5 3表达阳性 ;PI为 6.0 %~ 2 4.0 % (平均为 12 .3 % ) ,AI为 2 .0 %~ 8.0 % (平均为 5 .4% ) ;PI与肿瘤分级、分期密切关系 ,AI与肿瘤分级有明显关系。结论 明显增高的PI和AI与肿瘤恶性表型有关 ,提示在RCC中肿瘤细胞过度增殖伴有频繁的凋亡发生。 Objective To investigate the relaitonship between the immunohistochemical expression of bcl-2,p53,and proliferating cell nuclear antigen (PCNA) with cell propiferation,apoptosis in renal cell carcinoma (RCC).Methods Formalin-fixed and paraffin-embedded tissue blocks from 34 patients with RCC were studied.Immunoreactivity of bcl-2,p53 and PCNA were assessed immunohistochemically.Apoptosis was detected by terminal deoxy- nucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL).Results The expression of the bcl-2 protein was detected in 15 cases (44.1%),while that of the p53 protein was detectable in only 3 cases.bcl-2 positivity was not associated with any pathological parameters.The proliferative index (PI) ranged from 6.0% to 24.0% (mean 12.3%) and the apoptosis index (AI) from 2.0% to 8.0% (mean 5.4 %) in RCC.PI was closely associated with tumor grade and stage,and a significant relationship between AI and the tumor grade of RCC was seen.Conclusion Obviously increased PI and AI is correlated with the malignant phelotypes of tumors,suggesting active cell proliferation may be accompanied by frequent apoptosis in RCC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2003年第6期559-560,共2页 Chinese Journal of Experimental Surgery
关键词 肾细胞癌 bcl—2 P53 增殖细胞核抗原 细胞增殖 细胞凋亡 bcl-2 p53 Proliferating cell nuclear antigen Apoptosis Carcinoma renal
  • 相关文献

参考文献4

  • 1Vasavada SP, Novick AC, Willians BR. p53, bcl-2 and bax expression in renal cell carcinomas. Urology, 1998.51 : 1057-1061.
  • 2Uchida T, Wada C, Schitara T, et al. Infrequent involvment of p53 mutation and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma. J Urol, 1993, 150 : 1298-1301.
  • 3Lipponen P, Eskelinen M, Syrjanen K, et al. Expression of tumor-suppressor gene Rb, apoptosis-suppressing protein bcl-2 and c-myc have no independent prognostic value in renal adenocarcinoma. Br J Cancer,1995, 71:863-867.
  • 4Pammer J, Exner M, Regele H, et al. Expression of bcl-2, bcl-x, bax, and bak in renal cell carcinomas. Pathol Res Pract, 1998, 194:837-845.

同被引文献9

  • 1邵成浩,胡先贵,刘瑞,张怡杰,唐岩,曹贵松.血管内皮生长因子反义核酸对胰腺癌细胞增殖、凋亡和血管生成的影响[J].中华实验外科杂志,2006,23(1):18-20. 被引量:11
  • 2陶凯雄,吴相柏,王国斌,陈道达,张宁,李新明.RNA干扰靶向抑制表皮生长因子受体表达对大肠癌细胞增殖的影响[J].中华实验外科杂志,2006,23(7):789-791. 被引量:5
  • 3Tapon N,Harvey KF,Bell DW.Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.Cell,2002,110:467-478.
  • 4Wu S,Huang J,Dong J.Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with Salvador and warts.Cell,2003,114:445-456.
  • 5Paloma V.Cloning expression and mapping of hSav1 a novel human WW domain-containing gene.Biochemical and Biophysical Research Communications,2000,276:990-998.
  • 6Lowe SW,Cepero E,Evan G.Intrinsic tumour suppression.Nature,2004.432:307-315.
  • 7Evan GI,Vousden KH.Proliferation,cell cycle and apoptosis in cancer.Nature,2001,411:342-348.
  • 8Sudol M,Chen HI,Bougeret C,et al.Characterization of a novel protein-binding module-the WW domain.FEBS Lett,1995,369:67-71.
  • 9Ingham RJ,Colwill K.Howard C,et al.WW domains provide a platform for the assembly of multiprotein networks.Mol Cell Biol,2005,25:7092-7106.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部